Telephone therapy delivered to refugee children results in a significant drop in mental health symptoms and a far higher completion rate of treatment compared with in-person therapy, according to a first-of-its-kind led by the University of Surrey.
Deciphera says its drug for rare joint tumor succeeded in a PhIII study, will submit to FDA
Deciphera Pharmaceuticals’ experimental treatment for tenosynovial giant cell tumor passed a pivotal study, setting the biotech up to go for its second drug approval. In
October 31, 2023